Publications in collaboration with researchers from Fukushima Medical University Hospital (1)

2023

  1. TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer

    Future oncology (London, England), Vol. 19, Núm. 35, pp. 2349-2359